Short term betaine therapy fails to lower elevated fasting total plasma homocysteine concentrations in hemodialysis patients maintained on chronic folic acid supplementation
Open Access
- 28 February 1995
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 113 (1) , 129-132
- https://doi.org/10.1016/0021-9150(94)05466-v
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Serum betaine, N,N-dimethylglycine and N-methylglycine levels in patients with cobalamin and folate deficiency and related inborn errors of metabolismMetabolism, 1993
- Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemiaThe American Journal of Clinical Nutrition, 1993
- Betaine for treatment of homocystinuria caused by methylenetetrahydrofolate reductase deficiency.Archives of Disease in Childhood, 1989
- Folic acid—an innocuous means to reduce plasma homocysteineScandinavian Journal of Clinical and Laboratory Investigation, 1988
- Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Plasma Protein-Bound Homocyst(e)ine in Patients Requiring Chronic HaemodialysisClinical Science, 1983
- Homocystinuria — The Effects of Betaine in the Treatment of Patients Not Responsive to PyridoxineNew England Journal of Medicine, 1983
- A new enzymatic method for pyridoxal‐5‐phosphate determinationJournal of Inherited Metabolic Disease, 1981
- Accumulation of Sulphur-Containing Amino Acids Including Cysteine-Homocysteine in Patients on Maintenance HaemodialysisClinical Science, 1980